Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ASPIRA PATHLAB & DIAGNOSTICS LTD.

NSE : NABSE : 540788ISIN CODE : INE500C01017Industry : Hospital & Healthcare ServicesHouse : Private

BSE59.22-3.08 (-4.94 %)

PREV CLOSE ( ) 62.30

OPEN PRICE ( ) 59.19

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 586

TODAY'S LOW / HIGH ( )59.19 64.00

52 WK LOW / HIGH ( ) 25106.78

NSE

This Company is not listed in NSE

Quarters

Select year

( in Million)

Particulars

Dec 2024

Sep 2024

Jun 2024

Jun 2023

Audited / UnAudited

UnAudited

Net Sales

54.07

61.78

46.37

26.04

Total Expenditure

46.4

48.21

42.87

29.3

PBIDT (Excl OI)

7.67

13.57

3.5

-3.26

Other Income

0.89

0.76

0.92

Operating Profit

8.56

14.32

4.41

-2.26

Interest

0.94

0.79

0.81

0.98

Exceptional Items

PBDT

7.62

13.53

3.60

-3.24

Depreciation

3.86

3.64

3.77

3.92

Profit Before Tax

3.76

9.89

-0.16

-7.16

Tax

Provisions and contingencies

Profit After Tax

3.76

9.89

-0.16

-7.16

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

3.76

9.89

-0.16

-7.16

Minority Interest

Shares of Associates

-0.7

0.64

Other related items

Misc. Expenses Written off

Consolidated Net Profit

3.06

9.9

0.47

-7.16

Equity Capital

102.93

Face Value (IN RS)

Reserves

Calculated EPS

0.29

0.96

0.04

-0.69

Calculated EPS (Annualised)

1.18

3.84

0.18

-2.78

No of Public Share Holdings

8384036

8366036

8299627

% of Public Share Holdings

81.45

81.28

80.63

PBIDTM% (Excl OI)

14.18

21.96

7.54

-12.51

PBIDTM%

15.83

23.17

9.53

-8.67

PBDTM%

14.09

21.90

7.78

-12.44

PBTM%

6.95

16.00

-0.34

-27.49

PATM%

6.95

16.00

-0.34

-27.49

Notes

Risk Disclosures on Derivatives

Quarterly Results

ASPIRA PATHLAB & DIAGNOSTICS LTD.